Brand-name FDA-approved GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) remain in a different price category entirely - typically $900 to $1,300+ per month without insurance, with coverage and prior authorization requirements that exclude many patients
Considerations, properties, and an introduction to microdosing (34:58) Section 2 - The metabolic terrain: HRT and tirzepatide in women and men, and lab testing (52:53) Section 3 - Movement, nutrition, and behavior: training regime protocols (20:06) Section 3.1 - Time-restricted eating, nutritional education, and mindset tools for weight loss (31:26) Section 4 - Microdosing protocols and tracking progress: starting doses, titration strategies, and side effect mitigation (8:03) Section 5 - Practice model integration: memberships and marketing (21:38) Section 6 - Special populations, risks, and future vision: combining with microdosing and case study (18:36) Course Post-Test Downloadable Audio Lectures Additional Resources: Consent, Lab Orders, Policies, and More
The familiar system is still here, now simply called Points
Wegovy mainly targets a specific type of receptor called GLP-1, while Mounjaro goes a step further by also affecting GIP receptors
Garantert renhet: Laboratorietestet kvalitet med over 99 % renhetsgrad
